Glycotest, Inc.
PrivateLast Round
Series A
Extension
Jan 23, 2024
Est. Valuation
$25M
Total Funding Raised
$14.81M
Momentum Score
25 /100
Company Overview
Glycotest, Inc. is a diagnostics company founded in 2012 that specializes in the commercialization of non-invasive blood tests for the early detection of life-threatening liver cancers and fibrosis-cirrhosis. The company's core technology is based on proprietary, patent-protected serum glycoprotein biomarkers and assay technology innovated at Drexel University College of Medicine and the Baruch S. Blumberg Institute. Its lead product, the HCC Panel, is an algorithm-driven test designed to detect curable, early-stage liver cancer, aiming to outperform the current standard blood tests. Glycotest's mission is to revolutionize the care and treatment for the at-risk chronic liver disease population. The company is backed by investors including NetScientific plc, Fosun Pharma, and EMV Capital.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Glycotest, Inc. Comps
Public and private peers based on sector, stage, and business model.
Glycotest, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 23, 2024 | ||||
| Convertible Debt | May 2, 2023 | ||||
| Series A Extension | Nov 21, 2019 | ||||
| Series A | Oct 22, 2018 |
Key People
Founding team and executive leadership
Glycotest, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EMV Capital | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
Monthly visitors increased 118% MoM.
Glycotest, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Glycotest, Inc.'s valuation, stock price, and market status.
